Metraipolis › archive › dc_db82c3dec503

Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs — Europe PMC PMID:41199882

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41199882
DOI: 10.1016/j.omton.2025.201036
License (as archived): solo-consultazione
Archived: 2026-11-10T01:55:45.572Z
SHA-256 of the archived text: 049b6d35c31ce25c4a9cf1a8556fb2a53b0d28e6ef62564c284e5f9653362746
Stable URL of this page: https://metraipolis.com/documento/dc_db82c3dec503

How to cite

Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs — Europe PMC PMID:41199882 — Europe PMC (en), https://europepmc.org/article/MED/41199882 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_db82c3dec503 (Metraipolis archive dc_db82c3dec503, sha256 049b6d35c31ce25c4a9cf1a8556fb2a53b0d28e6ef62564c284e5f9653362746)

BibTeX

@misc{dcdb82c3dec503,
  title = {Nanobody-based canine PD-L1-targeting immune checkpoint inhibitors for cancer therapy in dogs — Europe PMC PMID:41199882},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41199882},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_db82c3dec503; sha256 049b6d35c31ce25c4a9cf1a8556fb2a53b0d28e6ef62564c284e5f9653362746},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41199882. Agents can read the archived copy with the MCP tool read_document.